Beyin Haritalama ve Tedavileri Derne\u011finin (Society for Brain Mapping and Therapeutics \u2013 SBMT) ABD ba\u015fta olmak \u00fczere sinirbilim alan\u0131ndaki se\u00e7kin ara\u015ft\u0131rmac\u0131lar\u0131n yer ald\u0131\u011f\u0131 21\u2019inci y\u0131ll\u0131k kongresi ABD\u2019nin Los Angeles \u015fehrinde yap\u0131ld\u0131.\n
2013 y\u0131l\u0131nda kurulan SBMT, Neuroscience20 (Beyin, Omurga ve Ruh Sa\u011fl\u0131\u011f\u0131) olarak yeniden adland\u0131r\u0131lan G20+ D\u00fcnya Beyin Haritalama ve Terap\u00f6tik Giri\u015fimi\u2019ne de \u00f6nc\u00fcl\u00fck etti. Bu giri\u015fim, beyin haritalamada nanoteknoloji, g\u00f6r\u00fcnt\u00fcleme, h\u00fccresel\/k\u00f6k h\u00fccre terap\u00f6tikleri, bilgi teknolojisi ve cihazlar\u0131 entegre eden k\u00fcresel bir konsorsiyum olu\u015fturmay\u0131 ama\u00e7l\u0131yor.\n
G\u00f6r\u00fcnt\u00fclemeden genomik ve nanoya kadar t\u00fcm n\u00f6rolojik bozukluklar\u0131 kapsayan, ABD ba\u015fta olmak \u00fczere sinirbilim alan\u0131ndaki se\u00e7kin ara\u015ft\u0131rmac\u0131lar\u0131n yer ald\u0131\u011f\u0131 y\u0131ll\u0131k kongrenin 21\u2019incisine T\u00fcrkiye\u2019den sadece \u00dcsk\u00fcdar \u00dcniversitesi ve NP\u0130STANBUL Hastanesi ara\u015ft\u0131rmac\u0131lar\u0131 kat\u0131ld\u0131. Kongreye \u00dcsk\u00fcdar \u00dcniversitesi Kurucu Rekt\u00f6r\u00fc Prof. Dr. Nevzat Tarhan ba\u015fkanl\u0131\u011f\u0131nda kat\u0131lan ara\u015ft\u0131rma ekibi, \u201cAdvances in Neuroimaging Techniques\u201d ve \u201d Addiction Medicine\u201d ba\u015fl\u0131kl\u0131 iki ayr\u0131 oturumda \u00fclkemizi temsil etti.\n
N\u00d6ROMORF\u0130K B\u0130LG\u0130SAYAR TEKNOLOJ\u0130LER\u0130N\u0130N DE TARTI\u015eILDI\u011eI SUNUMLARDA YER ALDI\n
Yeni nesil sinirbilim \u00e7al\u0131\u015fmalar\u0131n oda\u011f\u0131nda yer alacak olan n\u00f6romorfik bilgisayar teknolojilerinin tart\u0131\u015f\u0131ld\u0131\u011f\u0131 sunumlarda \u00dcsk\u00fcdar \u00dcniversitesinin; y\u00fcksek h\u0131z ve performans prensibi ile \u00e7al\u0131\u015fan cloud computing teknolojisi yerine, uygulamalar\u0131 ve bilgi i\u015flem kabiliyetini, onlara ihtiya\u00e7 duyan kullan\u0131c\u0131lara veya \u201cnesnelere\u201d yakla\u015ft\u0131rmak i\u00e7in tasarlanan \u201cedge computing\u201d teknolojisi d\u00f6n\u00fc\u015f\u00fcme \u00f6nc\u00fcl\u00fck etti.\n
T\u00dcRK\u0130YE\u2019DEN YAPILAN YAPTI\u011eI SUNUMLAR YO\u011eUN \u0130LG\u0130 \u00c7EKT\u0130\n
T\u00fcrkiye\u2019den \u00dcsk\u00fcdar \u00dcniversitesi ve NP\u0130STANBUL Hastanesi akademisyenlerinin yapt\u0131\u011f\u0131 sunumlar, ara\u015ft\u0131rmac\u0131lar\u0131n da yo\u011fun ilgisini \u00e7ekti.\n
NP\u0130STANBUL Hastanesi, geli\u015ftirdi\u011fi yeni \u00fcr\u00fcn ile Vielight firmas\u0131n\u0131n Alzheimer, Travmatik Beyin Hasar\u0131, Parkinson, Otizm, TSSB, Long-covid tedavilerinde kullan\u0131lan ve fotobiyomod\u00fclasyon (PBM) ad\u0131 verilen bir s\u00fcre\u00e7le, k\u0131rm\u0131z\u0131 ila NIR dalga boyu aral\u0131\u011f\u0131ndaki \u0131\u015f\u0131k enerjisi emilerek mitokondriyal sa\u011fl\u0131k iyile\u015ftiren, mitokondri, biyokimyasal reaksiyonlar\u0131 ve di\u011fer h\u00fccresel s\u00fcre\u00e7leri y\u00fcr\u00fctmek i\u00e7in enerji sa\u011flayan h\u00fccresel \u201cpiller\u201d gibi \u00e7al\u0131\u015farak teknoloji bili\u015fsel yetene\u011fi geli\u015ftiren ve serebral kan ak\u0131\u015f\u0131n\u0131 art\u0131ran The Vielight Neuro
PROF. DR. NEVZAT TARHAN SUNUMUNDA KL\u0130N\u0130K FARMAKOGENET\u0130K UYGULAMALARI PAYLA\u015eTI\n
D\u00fcnyan\u0131n bir\u00e7ok yerinden bilim insan\u0131n\u0131n kat\u0131ld\u0131\u011f\u0131 toplant\u0131da Prof. Dr. Nevzat Tarhan, \u201cUse of Pharmacogenomic Biomarkers as Pharmacokinetics and Pharmacodynamics\u201d ba\u015fl\u0131kl\u0131 sunum ger\u00e7ekle\u015ftirdi. Prof. Dr. Tarhan sunumunda, sinirbilim aln\u0131ndaki g\u00fcncel \u00e7al\u0131\u015fmalar\u0131n alt\u0131n\u0131 \u00e7izerken \u00fcniversitede y\u00fcr\u00fct\u00fclen ila\u00e7 kan d\u00fczeyi \u00f6l\u00e7\u00fcmleri ve klinik farmakogenetik uygulamalar\u0131n\u0131 payla\u015ft\u0131.\n
TDM (therapeutic drug monitoring, kanda ila\u00e7 d\u00fczeyi \u00f6l\u00e7\u00fcm\u00fc) uygulamalar\u0131n\u0131n hasta i\u00e7in uygun dozu se\u00e7mede \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131n\u0131n ve toksik ila\u00e7 d\u00fczeyi olu\u015fmas\u0131n\u0131 engelledi\u011finin alt\u0131n\u0131 \u00e7izen Prof. Dr. Tarhan, farmakogenetik profilleme sonu\u00e7lar\u0131n\u0131, beyinde dopamin miktar\u0131n\u0131 belirleyen COMT enzim aktivitesi ve serotonin ta\u015f\u0131y\u0131c\u0131 protein aktivitesi \u00f6l\u00e7\u00fcm \u00e7al\u0131\u015fmalar\u0131 ba\u015fl\u0131\u011f\u0131 alt\u0131na payla\u015ft\u0131.\n","created_at":"2024-03-18T19:34:10.000000Z","updated_at":"2024-03-18T19:34:10.000000Z"}